Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Terminated NCT02479386

A Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Conditions: Geographic Atrophy

Sex: All
Ages: 50 Years – N/A
Healthy volunteers: No
Enrollment: 296
Sponsor: Hoffmann-La Roche

Location: Northwest Arkansas Retina Associates Springdale Arkansas

Summary

This study seeks to better characterize relationships between visual function and the progression (worsening) of geographic atrophy (GA) due to age-related macular degeneration (AMD). The study is also intended to generate new information on the relationship between genetics and GA progression. This is a global, prospective, multicenter, epidemiologic study enrolling participants with GA secondary to AMD. The study visits are scheduled to occur every 6 months. The anticipated duration of the study is up to 48 months. There is a planned interim analysis around the 2-year time window for the study.

Eligibility Criteria

Inclusion Criteria: * For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods that result in a failure rate of less than (\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02479386). StuddyBuddy aggregates publicly available trial information.